171 related articles for article (PubMed ID: 21633298)
21. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
[TBL] [Abstract][Full Text] [Related]
22. Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.
Gilks CB; Young RH; Gersell DJ; Clement PB
Am J Surg Pathol; 1997 Aug; 21(8):905-14. PubMed ID: 9255253
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
25. Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors.
Lee JP; Chang KH; Han JH; Ryu HS
Int J Gynecol Cancer; 2005; 15(1):113-9. PubMed ID: 15670305
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of survivin, Fas and FasL contributed to cervical cancer development and metastasis.
Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
28. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
29. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
[TBL] [Abstract][Full Text] [Related]
30. Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis.
Lu H; Gan M; Zhang G; Zhou T; Yan M; Wang S
Eur J Gynaecol Oncol; 2010; 31(6):662-6. PubMed ID: 21319512
[TBL] [Abstract][Full Text] [Related]
31. Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma.
Yu L; Suye S; Huang R; Liang Q; Fu C
J Clin Pathol; 2021 Dec; 74(12):787-795. PubMed ID: 33060116
[TBL] [Abstract][Full Text] [Related]
32. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine carcinoma of the uterine cervix: a single institution case review.
Niu X; Gilbert L
Eur J Gynaecol Oncol; 2011; 32(4):377-80. PubMed ID: 21941956
[TBL] [Abstract][Full Text] [Related]
34. The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung.
Casali C; Stefani A; Rossi G; Migaldi M; Bettelli S; Parise A; Morandi U
Ann Thorac Surg; 2004 Jan; 77(1):247-52; discussion 252-3. PubMed ID: 14726070
[TBL] [Abstract][Full Text] [Related]
35. Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.
Werner TA; Tamkan-Ölcek Y; Dizdar L; Riemer JC; Wolf A; Cupisti K; Verde PE; Knoefel WT; Krieg A
Br J Cancer; 2016 Feb; 114(4):427-34. PubMed ID: 26882066
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of FIGO stage I-IIA small-cell neuroendocrine carcinoma of the uterine cervix.
Ning L; Zhang W; Yang J; Cao D; Lang J; Yu M
Int J Gynaecol Obstet; 2018 Sep; 142(3):374-375. PubMed ID: 29858870
[No Abstract] [Full Text] [Related]
37. Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy.
Nishioka T; West CM; Gupta N; Wilks DP; Hendry JH; Davidson SE; Hunter RD
J Cancer Res Clin Oncol; 1999; 125(2):96-100. PubMed ID: 10190316
[TBL] [Abstract][Full Text] [Related]
38. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
[TBL] [Abstract][Full Text] [Related]
39. Large cell neuroendocrine carcinoma of the uterine cervix.
Habeeb A; Habeeb H
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642849
[TBL] [Abstract][Full Text] [Related]
40. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
